- Home
- GDL vs NAUT Comparison
GDL vs NAUT Comparison
Compare GDL & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDL
- NAUT
- Stock Information
- Founded
- GDL 2006
- NAUT 2016
- Country
- GDL United States
- NAUT United States
- Employees
- GDL N/A
- NAUT N/A
- Industry
- GDL Investment Managers
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- GDL Finance
- NAUT Industrials
- Exchange
- GDL Nasdaq
- NAUT Nasdaq
- Market Cap
- GDL 94.9M
- NAUT 104.7M
- IPO Year
- GDL N/A
- NAUT N/A
- Fundamental
- Price
- GDL $8.51
- NAUT $1.50
- Analyst Decision
- GDL
- NAUT Strong Sell
- Analyst Count
- GDL 0
- NAUT 1
- Target Price
- GDL N/A
- NAUT $1.75
- AVG Volume (30 Days)
- GDL 11.2K
- NAUT 830.4K
- Earning Date
- GDL 01-01-0001
- NAUT 10-28-2025
- Dividend Yield
- GDL 6.02%
- NAUT N/A
- EPS Growth
- GDL N/A
- NAUT N/A
- EPS
- GDL N/A
- NAUT N/A
- Revenue
- GDL N/A
- NAUT N/A
- Revenue This Year
- GDL N/A
- NAUT N/A
- Revenue Next Year
- GDL N/A
- NAUT N/A
- P/E Ratio
- GDL N/A
- NAUT N/A
- Revenue Growth
- GDL N/A
- NAUT N/A
- 52 Week Low
- GDL $7.65
- NAUT $0.62
- 52 Week High
- GDL $8.13
- NAUT $2.92
- Technical
- Relative Strength Index (RSI)
- GDL 51.31
- NAUT 57.92
- Support Level
- GDL $8.45
- NAUT $1.44
- Resistance Level
- GDL $8.53
- NAUT $1.87
- Average True Range (ATR)
- GDL 0.06
- NAUT 0.25
- MACD
- GDL 0.00
- NAUT 0.00
- Stochastic Oscillator
- GDL 79.41
- NAUT 48.68
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.